FRES
Price
$0.85
Change
-$0.27 (-24.11%)
Updated
Dec 23 closing price
Capitalization
2.08M
QURE
Price
$15.48
Change
+$0.19 (+1.24%)
Updated
Jan 23, 04:15 PM (EDT)
Capitalization
817.06M
39 days until earnings call
Ad is loading...

FRES vs QURE

Header iconFRES vs QURE Comparison
Open Charts FRES vs QUREBanner chart's image
Fresh2 Group
Price$0.85
Change-$0.27 (-24.11%)
Volume$285.05K
Capitalization2.08M
uniQure
Price$15.48
Change+$0.19 (+1.24%)
Volume$375
Capitalization817.06M
FRES vs QURE Comparison Chart
Loading...
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FRES vs. QURE commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRES is a Hold and QURE is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (FRES: $0.85 vs. QURE: $15.29)
Brand notoriety: FRES and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRES: 204% vs. QURE: 20%
Market capitalization -- FRES: $2.08M vs. QURE: $817.06M
FRES [@Biotechnology] is valued at $2.08M. QURE’s [@Biotechnology] market capitalization is $817.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRES’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • FRES’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, both FRES and QURE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FRES’s TA Score shows that 1 TA indicator(s) are bullish while QURE’s TA Score has 2 bullish TA indicator(s).

  • FRES’s TA Score: 1 bullish, 1 bearish.
  • QURE’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, FRES is a better buy in the short-term than QURE.

Price Growth

FRES (@Biotechnology) experienced а 0.00% price change this week, while QURE (@Biotechnology) price change was +9.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.05%. For the same industry, the average monthly price growth was +3.28%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

FRES is expected to report earnings on May 16, 2023.

QURE is expected to report earnings on May 05, 2025.

Industries' Descriptions

@Biotechnology (+4.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($817M) has a higher market cap than FRES($2.09M). FRES YTD gains are higher at: 0.000 vs. QURE (-13.420). FRES has higher annual earnings (EBITDA): -131.06M vs. QURE (-157.84M). QURE has higher revenues than FRES: QURE (28.6M) vs FRES (17M).
FRESQUREFRES / QURE
Capitalization2.09M817M0%
EBITDA-131.06M-157.84M83%
Gain YTD0.000-13.420-
P/E RatioN/AN/A-
Revenue17M28.6M59%
Total CashN/A435M-
Total DebtN/A67.6M-
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FRESQURE
RSI
ODDS (%)
N/A
Bearish Trend 16 days ago
88%
Stochastic
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
Momentum
ODDS (%)
Bullish Trend 16 days ago
75%
Bearish Trend 16 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 16 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
85%
Bearish Trend 16 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
67%
View a ticker or compare two or three
Ad is loading...
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLMSX21.860.15
+0.69%
Morgan Stanley Instl Global Core R6
INIVX11.470.01
+0.09%
VanEck International Investors Gold A
SGICX17.12N/A
N/A
SGI US Large Cap Equity C
FSCIX34.06-0.15
-0.44%
Fidelity Advisor Small Cap I
FTYCX46.09-0.27
-0.58%
FullerThaler Behavioral Sm-Cp Eq C

FRES and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRES has been closely correlated with HOOK. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
N/A
HOOK - FRES
75%
Closely correlated
-2.45%
KZIA - FRES
57%
Loosely correlated
-4.86%
NKTR - FRES
34%
Loosely correlated
+1.55%
QURE - FRES
32%
Poorly correlated
+2.55%
KPRX - FRES
31%
Poorly correlated
-3.25%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with CMRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+2.55%
CMRX - QURE
58%
Loosely correlated
-1.56%
HOOK - QURE
44%
Loosely correlated
-2.45%
AXON - QURE
42%
Loosely correlated
+0.33%
NAMS - QURE
39%
Loosely correlated
-1.39%
SNGX - QURE
37%
Loosely correlated
+2.50%
More